The activation of phosphatidylinositol 3-kinase by Ras

Tsutomu Kodaki , Rüdiger Woscholski , Bengt Hallberg , Pablo Rodriguez-Viciana Julian Downward
Current Biology 4 ( 9) 798 -806

298
1994
A novel complex comprising BRaf, PKCϵ and S6K2 mediates the pro-survival effects of FGF-2 in small cell lung cancer cells

Richard Marias , Neil Sebire , Ivan Gout , Michael Seckl
Cancer Research 67 2522 -2522

2007
83
2003
The ubiquitin-proteasome pathway regulates survivin degradation in a cell cycle-dependent manner

Julian Downward , Nicholas R. Lemoine , Luis M. Martins , Jian Zhao
Journal of Cell Science 113 ( 23) 4363 -4371

242
2000
Ras induces NBT-II epithelial cell scattering through the coordinate activities of Rac and MAPK pathways.

Natacha Edme , Julian Downward , Jean-Paul Thiery , Brigitte Boyer
Journal of Cell Science 115 ( 12) 2591 -2601

77
2002
Abstract #LB-277: An siRNA screen identifies RSK family members as key regulator of lung cancer metastasis

Michael Seckl , Daniel Zicha , Julian Downward , Romain Lara
Cancer Research 69

2009
Chromosomal instability determines taxane sensitivity - supplementary materials

Maik Kschischo , Barbara Nicke , Thomas Ried , Julian Downward

2009
Abstract B26: The SHOC2 phosphatase complex as a therapeutic target for ERK-pathway inhibition in RAS-driven tumors

Pablo Rodriguez-Viciana , Miriam Molina-Arcas , Julian Downward , Mona A. El-Bahrawy
Molecular Cancer Research 18

2020
Abstract B11: RAS orchestrates the increase of interstitial adenosine in lung adenocarcinoma to promote immune evasion

Julian Downward , Chris Moore , Sophie de Carné , Philip East
Cancer immunology research 8

2020
Abstract B19: New tools to study the role of RAS/CRAF interaction in RAS-driven lung cancer

Miriam Molina-Arcas , Julian Downward , Ian Rosewell , David Hancock
Molecular Cancer Research 18

2020
2020
Quantitative Proteomic Analysis in Alveolar Type II Cells Reveals the Different Capacities of RAS and TGF-β to Induce Epithelial–Mesenchymal Transition

Julian Downward , Mark G. Jones , Paul Skipp , Donna E. Davies
Frontiers in Molecular Biosciences 8 595712 -595712

2021
Correction: WDHD1 is essential for the survival of PTEN-inactive triple-negative breast cancer.

Marcin R Przewloka , Julian Downward , Paul Skipp , Rob M Ewing
Cell Death and Disease 12 ( 3) 269 -269

2021
Clinical impact of subclonal EGFR T790M mutations in advanced-stage EGFR-mutant non-small-cell lung cancers

Julian Downward , Aleksandra Markovets , Elza C de Bruin , Kenneth S Thress
Nature Communications 12 ( 1) 1780 -1780

2021
Determination of synthetic lethal interactions in KRAS oncogene-dependent cancer cells reveals novel therapeutic targeting strategies

Michael Steckel , Miriam Molina-Arcas , Britta Weigelt , Michaela Marani
Cell Research 22 ( 8) 1227 -1245

196
2012
Relationship of Extreme Chromosomal Instability with Long-term Survival in a Retrospective Analysis of Primary Breast Cancer

Rebecca Roylance , David Endesfelder , Patricia Gorman , Rebecca A Burrell
Cancer Epidemiology, Biomarkers & Prevention 20 ( 10) 2183 -2194

107
2011
Interleukin (IL)-2 activation of p21ras in murine myeloid cells transfected with human IL-2 receptor β chain

Warren J. Leonard , Doreen A. Cantrell , Manuel Izquierdo , Julian Downward
European Journal of Immunology 22 ( 3) 817 -821

24
1992
How BAD phosphorylation is good for survival.

Julian Downward
Nature Cell Biology 1 ( 2)

210
1999
124
2000